Journal of Clinical Oncology , 0732-183X
Journal
Publications
- 2020
- E-pub ahead of print
Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia
Charles Craddock, Aimee Jackson, Justin Loke, Ram Malladi, Keith Wheatley & 7 others, , 29 Dec 2020, In: Journal of Clinical Oncology . 12 p., JCO2002308.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses
Sylvie Freeman, 23 Dec 2020, In: Journal of Clinical Oncology . p. JCO2001170Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study
Aneel Bhangu, 6 Oct 2020, In: Journal of Clinical Oncology . 14 p., JCO2001933.Research output: Contribution to journal › Article › peer-review
- Published
De-escalation after DE-ESCALATE and RTOG 1016: a head and neck cancer InterGroup framework for future de-escalation studies
Hisham Mehanna, 1 Aug 2020, In: Journal of Clinical Oncology . 38, 22, p. 2552-2557 7 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials
Daniel Rea, 24 Jul 2020, In: Journal of Clinical Oncology . p. JCO1902427Research output: Contribution to journal › Article › peer-review
- Published
Less is not necessarily more: toward a rational selection of the conditioning regimen in acute myeloid leukemia
Sylvie Freeman, 20 Apr 2020, In: Journal of Clinical Oncology . 38, 12, p. 1249-1251 3 p.Research output: Contribution to journal › Editorial
- Published
ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).
Simon Bach, 2020, In: Journal of Clinical Oncology . p. 4101-410 9 p.Research output: Contribution to journal › Article › peer-review
- 2019
- Published
Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study
Kristian Brock, Sam Munoz Vicente, Becky Boucher, 20 Oct 2019, In: Journal of Clinical Oncology . 37, 30, p. 2722-2729 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.
Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, 20 May 2019, In: Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.Research output: Contribution to journal › Abstract › peer-review
- Published
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Hoare, Kristian Brock & Christina Yap, 1 Mar 2019, In: Journal of Clinical Oncology . 37, 7, p. 580-588 9 p., JCO1800889.Research output: Contribution to journal › Article › peer-review
- Published
High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: Results of the european ewing tumour working initiative of national groups, 99 trial and ewing 2008
& 22 others, , 1 Jan 2019, In: Journal of Clinical Oncology. 37, 34, p. 3192-3202 11 p.Research output: Contribution to journal › Article › peer-review
- 2018
- E-pub ahead of print
High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-E.W.I.N.G.99 and Ewing-2008
6 Sep 2018, In: Journal of Clinical Oncology . 16 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features
Keith Wheatley, 28 Aug 2018, In: Journal of Clinical Oncology .Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Risk, risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: a review
Raoul Reulen, 6 Jun 2018, In: Journal of Clinical Oncology . 36, 9 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Development and validation of a combined metabolic and immune prognostic classifier for head and neck cancer
Jill Brooks, Lucinda Archer, Rachel Spruce, Nikos Batis, Jennifer Bryant, Andrew Beggs, Daniel Tennant, Gary Middleton, Jean-Baptiste Cazier, Benjamin Willcox, 1 Jun 2018, In: Journal of Clinical Oncology. 36, 15 Suppl, p. 6049-6049Research output: Contribution to journal › Abstract › peer-review
- Published
Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations
Sylvie Freeman, Naeem Khan, 20 May 2018, In: Journal of Clinical Oncology . 36, 15, p. 1486-1497 12 p.Research output: Contribution to journal › Article › peer-review
- Published
Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial
Pamela Kearns, 1 May 2018, In: Journal of Clinical Oncology . 36, 13, p. 1330-1338 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data
& 12 others, , 1 Apr 2018, In: Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.Research output: Contribution to journal › Article › peer-review
- Published
Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)
9 Feb 2018, In: Journal of Clinical Oncology . 36, Suppl 6S, Abstract 407.Research output: Contribution to journal › Abstract › peer-review
- 2017
- Published
Improving outcomes in high-risk Myelodysplasia: Festina Lente
Charles Craddock, 26 May 2017, In: Journal of Clinical Oncology . p. JCO2017730812Research output: Contribution to journal › Editorial › peer-review